Physician Assistant, Medical · Brooklyn, NY
NPI
1225226756
Since 2007
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1632 E 16th St
Brooklyn, NY, 11229
Phone (718) 336-0330
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
298 services
Medicare patients, 2024
133
Average age 77
Drug cost, 2024
$2.3M
11,655 prescriptions
Company payments, 2025
$603
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Inna Chernoglaz was code 99211 (office e&m - established), 65 times for 56 patients. In total Inna Chernoglaz billed 298 services in 29 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-03-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99211 Office E&M - Established | Office | 65 | 56 | $15.05 | $978 |
| 99214 Office E&M - Established | Office | 62 | 58 | $77.08 | $4,779 |
| 99213 Office E&M - Established | Office | 50 | 44 | $61.83 | $3,092 |
| 93000 Electrocardiogram | Office | 22 | 22 | $9.15 | $201 |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 16 | 15 | $24.12 | $386 |
By year: 2022 $7,211 for 158 services; 2023 $22K for 537 services; 2024 $12K for 298 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 23 | 22 | $8.40 | $193 |
Medicare prescription drug claims, 2024
In 2024, the drug Inna Chernoglaz prescribed most often to Medicare patients was Vascepa (Icosapent Ethyl), with 407 prescriptions and refills. In total Inna Chernoglaz wrote 11,655 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vascepa Icosapent Ethyl | 407 | 423 | 65 | $142K |
| Atorvastatin Calcium Generic | 399 | 559 | 81 | $1,422 |
| Diclofenac Sodium Generic | 360 | 399 | 71 | $231K |
| Metformin Hcl Generic | 338 | 476 | 64 | $894 |
| Rosuvastatin Calcium Generic | 335 | 395 | 73 | $1,877 |
| Amlodipine Besylate Generic | 300 | 340 | 53 | $698 |
| Metoprolol Succinate Generic | 298 | 335 | 52 | $1,754 |
| Losartan Potassium Generic | 289 | 357 | 49 | $1,358 |
| Linzess Linaclotide | 253 | 267 | 44 | $136K |
| Omeprazole Generic | 222 | 268 | 45 | $820 |
| Creon Lipase/Protease/Amylase | 211 | 237 | 41 | $258K |
| Synthroid Levothyroxine Sodium | 208 | 235 | 32 | $8,752 |
| Clopidogrel Clopidogrel Bisulfate | 207 | 223 | 32 | $609 |
| Gabapentin Generic | 167 | 183 | 32 | $826 |
| Myrbetriq Mirabegron | 163 | 169 | 26 | $75K |
Brand drugs: 3,514 claims; generic drugs: 7,935 claims; opioid claims: 51.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Inna Chernoglaz $603 ($603 in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbvie Inc. with $151.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 8 | $151 |
| Novo Nordisk Inc NVO | 5 | $110 |
| Esperion Therapeutics, Inc. ESPR | 4 | $85.16 |
| Astellas Pharma US Inc 4503.T | 2 | $54.16 |
| Amgen Inc. AMGN | 2 | $44.51 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $33.56 |
| Abbott Laboratories ABT | 1 | $26.32 |
| Ardelyx, Inc. ARDX | 1 | $23.99 |
| Aimmune Therapeutics, Inc. | 1 | $23.81 |
| Vifor Pharma, Inc. | 1 | $18.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.